Suven Pharmaceuticals Q4 Results
- BSE: 543064
- NSE: SUVENPHAR
- ISIN: INE03QK01018
- Sector: Biotechnology & Drugs
BSE
1,169.45
36.40 (3.21%)
36.40 (3.21%)Volume9.36 K
Updated: Wed 19 Mar, 2025 | 15:29:08
NSE
1,167.7534.00 (3.00%)
34.00 (3.00%)Volume4.79 L
Updated: Wed 19 Mar, 2025 | 15:29:55
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Suven Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 24 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 252.93 | 307.15 | 15.06% | 369.36 | -31.52% |
| Selling/ General/ Admin Expenses Total | 45.77 | 63.29 | 39.40% | 25.60 | 78.76% |
| Depreciation/ Amortization | 17.41 | 20.35 | 36.54% | 11.96 | 45.60% |
| Other Operating Expenses Total | 5.12 | 70.53 | -64.47% | 15.77 | -67.51% |
| Total Operating Expense | 194.46 | 209.80 | 16.15% | 212.24 | -8.37% |
| Operating Income | 58.47 | 97.35 | 11.59% | 157.12 | -62.79% |
| Net Income Before Taxes | 70.85 | 109.73 | 8.22% | 166.21 | -57.37% |
| Net Income | 53.37 | 82.88 | 14.16% | 123.97 | -56.95% |
| Diluted Normalized EPS | 2.20 | 3.23 | 19.32% | 4.87 | -54.88% |